BlackRock, Inc. (BLK) 13D/13G Filings for Krystal Biotech, Inc. (KRYS)

BlackRock, Inc. 13D and 13G filings for Krystal Biotech, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-07-08
4:32 pm
Purchase
2024-06-3013GKrystal Biotech, Inc.
KRYS
BlackRock Inc.
BLK
3,947,588
13.800%
2,138,211increase
(+118.17%)
Filing
2024-01-29
3:26 pm
Purchase
2023-12-3113GKrystal Biotech, Inc.
KRYS
BlackRock Inc.
BLK
1,809,377
6.400%
110,952increase
(+6.53%)
Filing
2023-01-31
5:52 pm
Purchase
2022-12-3113GKrystal Biotech, Inc.
KRYS
BlackRock Inc.
BLK
1,698,425
6.600%
92,929increase
(+5.79%)
Filing
2022-02-03
4:41 pm
Purchase
2021-12-3113GKrystal Biotech, Inc.
KRYS
BlackRock Inc.
BLK
1,605,496
6.400%
198,148increase
(+14.08%)
Filing
2021-02-02
3:13 pm
Purchase
2020-12-3113GKrystal Biotech, Inc.
KRYS
BlackRock Inc.
BLK
1,407,348
7.100%
1,407,348increase
(New Position)
Filing